Company / Current Liabilities per Share
Pacira BioSciences, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.61
FY2025
5-year range
$2.12 / $11.94
FY2021-FY2025
Trend
-61.1%
vs FY2024
Sector context
#57 of 210
Health Care
What the data says
At $2.61, Pacira BioSciences, Inc.'s current liabilities per share ranks #154 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.22 in FY2016 to $11.94 in FY2021.
Based on SEC 10-K filings.
2.61 in FY2025 with a 5-year CAGR of -15.5%.
Increased from $2.12 to $2.61 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -7.6%
- 5-Year CAGR
- -15.5%
- 10-Year CAGR
- -
Sector benchmark
-83.5% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 61.1% year-over-year.
- Ranks #57 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.61 | -61.1% |
| FY2024 | $6.70 | +216.1% |
| FY2023 | $2.12 | -35.8% |
| FY2022 | $3.30 | -72.3% |
| FY2021 | $11.94 | +97.6% |
| FY2020 | $6.04 | +131.4% |
| FY2019 | $2.61 | +75.1% |
| FY2018 | $1.49 | -0.6% |
| FY2017 | $1.50 | +23.3% |
| FY2016 | $1.22 | -70.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026